06 November 2026

Circular No. (46/2026) GUIDELINE FOR HANDLING PEPTIDE PRODUCTS AND MOLECULES

Reference: CIR-2026-00000207

GUIDELINE FOR HANDLING PEPTIDE PRODUCTS AND MOLECULES

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the Emirates Drug Establishment for perusal and adherence to what is stated.

 

Circular No. (46/2026)  GUIDELINE FOR HANDLING PEPTIDE PRODUCTS AND MOLECULES

 

Thanks in advance for your good co-operation

 

 Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

تعميم رقم 46 - 2026 بشأن ضوابط التعامل مع المنتجات والمركبات الببتيدية_.pdf:

View Document